Citius Oncology, Inc. (CTOR) bonds
CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
$0.57+0.05 (+9.86%)
Close on Nov 13, 2026Market cap $53.35MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$6.41M
Long-term debt
Net debt
-$10.15M
After $16.56M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
-107.9×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Citius Oncology's 10-Q for the period ended May 6, 2026
| Issue | Amount issued |
|---|---|
| Loan | $25.00M |
| Unsecured Promissory Note | $3.80M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?